메뉴 건너뛰기




Volumn 393, Issue 6, 2008, Pages 929-934

R2 resection in pancreatic cancer - Does it make sense?

Author keywords

Pancreatic cancer; Pancreatic surgery; R2 resection

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BODY MASS; BYPASS SURGERY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HEART DISEASE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATING ROOM PERSONNEL; OPERATION DURATION; PANCREAS CANCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 53549085986     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-008-0308-4     Document Type: Article
Times cited : (35)

References (21)
  • 1
    • 0023717332 scopus 로고
    • Pancreatic cancer in 1988. Possibilities and probabilities
    • AL Warshaw RS Swanson 1988 Pancreatic cancer in 1988. Possibilities and probabilities Ann Surg 208 541 553
    • (1988) Ann Surg , vol.208 , pp. 541-553
    • Warshaw, A.L.1    Swanson, R.S.2
  • 2
    • 0023626809 scopus 로고
    • Cancer of the pancreas. 50 years of surgery
    • B Gudjonsson 1987 Cancer of the pancreas. 50 years of surgery Cancer 60 2284 2303
    • (1987) Cancer , vol.60 , pp. 2284-2303
    • Gudjonsson, B.1
  • 5
    • 0031718349 scopus 로고    scopus 로고
    • Pancreatic cancer: 1998 update
    • CJ Yeo 1998 Pancreatic cancer: 1998 update J Am Coll Surg 187 429 442
    • (1998) J Am Coll Surg , vol.187 , pp. 429-442
    • Yeo, C.J.1
  • 6
    • 31644449748 scopus 로고    scopus 로고
    • Microscopically incomplete resection offers acceptable palliation in pancreatic cancer
    • K Kuhlmann CS de HT van O Busch GT van H Obertop D Gouma 2006 Microscopically incomplete resection offers acceptable palliation in pancreatic cancer Surgery 139 188 196
    • (2006) Surgery , vol.139 , pp. 188-196
    • Kuhlmann, K.1    De, C.S.2    Van, H.T.3    Busch, O.4    Van, G.T.5    Obertop, H.6    Gouma, D.7
  • 7
    • 0035405115 scopus 로고    scopus 로고
    • Advances in the surgical management of pancreatic cancer
    • K Spanknebel KC Conlfson 2001 Advances in the surgical management of pancreatic cancer Cancer J 7 312 323
    • (2001) Cancer J , vol.7 , pp. 312-323
    • Spanknebel, K.1    Conlfson, K.C.2
  • 9
    • 0034128217 scopus 로고    scopus 로고
    • Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: An institutional experience
    • C Chao JP Hoffman EA Ross MH Torosian BL Eisenberg 2000 Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience Am Surg 66 378 385
    • (2000) Am Surg , vol.66 , pp. 378-385
    • Chao, C.1    Hoffman, J.P.2    Ross, E.A.3    Torosian, M.H.4    Eisenberg, B.L.5
  • 10
    • 0030068586 scopus 로고    scopus 로고
    • Radical reoperation for advanced pancreatic carcinoma
    • PA Johnstone WF Sindelar 1996 Radical reoperation for advanced pancreatic carcinoma J Surg Oncol 61 7 11
    • (1996) J Surg Oncol , vol.61 , pp. 7-11
    • Johnstone, P.A.1    Sindelar, W.F.2
  • 11
    • 32144453709 scopus 로고    scopus 로고
    • Surgery for advanced and metastatic pancreatic cancer-current state and perspectives
    • O Mann T Strate C Schneider EF Yekebas JR Izbicki 2006 Surgery for advanced and metastatic pancreatic cancer-current state and perspectives Anticancer Res 26 681 686
    • (2006) Anticancer Res , vol.26 , pp. 681-686
    • Mann, O.1    Strate, T.2    Schneider, C.3    Yekebas, E.F.4    Izbicki, J.R.5
  • 13
    • 2442490662 scopus 로고    scopus 로고
    • Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma
    • M Wagner C Redaelli M Lietz CA Seiler H Friess MW Buchler 2004 Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586 594
    • (2004) Br J Surg , vol.91 , pp. 586-594
    • Wagner, M.1    Redaelli, C.2    Lietz, M.3    Seiler, C.A.4    Friess, H.5    Buchler, M.W.6
  • 15
    • 34548316162 scopus 로고    scopus 로고
    • Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: A phase I/II trial
    • J Schmidt T Welsch D Jager PF Muhlradt MW Buchler A Marten 2007 Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial Br J Cancer 97 598 604
    • (2007) Br J Cancer , vol.97 , pp. 598-604
    • Schmidt, J.1    Welsch, T.2    Jager, D.3    Muhlradt, P.F.4    Buchler, M.W.5    Marten, A.6
  • 17
    • 33845502537 scopus 로고    scopus 로고
    • Transforming growth factor-beta: What every pancreatic surgeon should know
    • MJ Truty R Urrutia 2007 Transforming growth factor-beta: what every pancreatic surgeon should know Surgery 141 1 6
    • (2007) Surgery , vol.141 , pp. 1-6
    • Truty, M.J.1    Urrutia, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.